The prognostic impact of main bronchial lymph node involvement in non-small cell lung carcinoma: suggestions for a modification of the staging system.

[1]  N. Willich,et al.  Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer. , 2008, The Lancet. Oncology.

[2]  Noriyuki Misaki,et al.  Prognostic Factors in Patients with Pathologic T1-2N1M0 Disease in Non-small Cell Carcinoma of the Lung , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[3]  G. Giaccone,et al.  Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. , 2007, Journal of the National Cancer Institute.

[4]  E. Paci,et al.  Prognostic variability among nonsmall cell lung cancer patients with pathologic N1 lymph node involvement , 2006, Cancer.

[5]  M. Okada,et al.  Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors. , 2005, The Journal of thoracic and cardiovascular surgery.

[6]  K. Yasumoto,et al.  Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer. , 2004, Lung cancer.

[7]  Tao-Sheng Li,et al.  Independent predictive value of the overall number of metastatic N1 and N2 stations in lung cancer. , 2003, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[8]  A. Marra,et al.  Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis. , 2003, The Journal of thoracic and cardiovascular surgery.

[9]  P. Goldstraw,et al.  Inter-observer variability in systematic nodal dissection: comparison of European and Japanese nodal designation. , 2002, The Annals of thoracic surgery.

[10]  K. Esato,et al.  Hilar Lymph Nodes in N2 Disease: Survival Analysis of Patients with Non-Small Cell Lung Cancers and Regional Lymph Node Metastasis , 2002, Surgery Today.

[11]  H. Asamura,et al.  Where is the boundary between N1 and N2 stations in lung cancer? , 2000, The Annals of thoracic surgery.

[12]  A. Dujon,et al.  Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung. , 1999, The Annals of thoracic surgery.

[13]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[14]  C. Mountain,et al.  Regional lymph node classification for lung cancer staging. , 1997, Chest.

[15]  R. Snijder,et al.  Lymph node type as a prognostic factor for survival in T2 N1 M0 non-small cell lung carcinoma. , 1997, The Annals of thoracic surgery.

[16]  Y. Ichinose,et al.  Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes. , 1994, The Journal of thoracic and cardiovascular surgery.

[17]  V. Rusch,et al.  Survival after resection of stage II non-small cell lung cancer. , 1992, The Annals of thoracic surgery.

[18]  C. Mountain.  The new International Staging System for Lung Cancer. , 1986, The Surgical clinics of North America.

[19]  T. Naruke,et al.  Lymph node mapping and curability at various levels of metastasis in resected lung cancer. , 1978, The Journal of thoracic and cardiovascular surgery.